Pharma Cinq, LLC

City:

Rockville, Maryland

Country:

United States

Published Applications:

Last publication date:

2023-12-28

Patent Grants:

Last grant date:

2026-05-19

Top Inventors for applications by Pharma Cinq, LLC

These are the the leading inventors for applications assigned to Pharma Cinq, LLC:

Reid Warren VON BORSTEL 4 Potomac, MD United States
Rolando Alejandro GARCIA GARCIA 4 Germantown, MD United States
David Michael SIMPSON 4 North Bethesda, MD United States
Joel A. SAYDOFF 1 Vista, CA United States

Jun ZHANG 1 Ellicott City, MD United States
Dennis Bryan Zerby 1 Chambersburg, PA United States
Tianci LUO 1 Fulton, MD United States
Stephen Wolpe 1 Boyds, MD United States

Reid W. von BORSTEL 1 Potomac, MD United States
Rui Li 1 Darnestown, MD United States
SIMPSON David Michael 1 North Bethesda, MD United States
Ming LU 1 Bethesda, MD United States

Julian Reading 1 Frederick, MD United States

Recent patent applications by Pharma Cinq, LLC

Pharma Cinq, LLC based in Rockville, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2023-12-28 ✅ Patent 12,630,580 granted on 2026-05-19

US20230416292A1

Chemistry; metallurgy

5'-O-Phenylacetyluridine and therapeutic use

#2 | 2023-12-28 ✅ Patent 12,649,739 granted on 2026-06-09

US20230416244A1

Chemistry; metallurgy

IMIDAZOQUINOLINE COMPOUND HAVING ANTI-INFLAMMATORY, ANTIFUGAL, ANTIPARASITIC, AND ANTICANCER ACTIVITY

#3 | 2023-11-09 ✅ Patent 12,577,270 granted on 2026-03-17

US20230357304A1

Chemistry; metallurgy

2′,3′-Diacetyluridine Substituted With Acetoacetyl at the 5′ Position

#4 | 2021-06-24 ✅ Patent 12,558,368 granted on 2026-02-24

US20210187001A1

Human necessities

Compositions and Devices for Systemic Delivery of Uridine

#5 | 2021-06-03 ✅ Patent 12,139,483 granted on 2024-11-12

US20210163476A1

Chemistry; metallurgy

Imidazoquinolyl compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity

#6 | 2021-06-03 ✅ Patent 12,076,367 granted on 2024-09-03

US20210162005A1

Human necessities

Fusion protein between short form rod-derived cone viability factor and a hydrophilic peptide

Also check out PHARMA CINQ, LLC's (Rockville, United States) applicant profile with 14 patent applications submitted.

AssigneeID:

623482 ⎘